Fujisawa, Japan

Kazunobu Tokunaga

This inventor holds 1 USPTO granted patent. Top assignee: Seiren Kabushiki Kaisha. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazunobu Tokunaga. Retrieved from https://idiyas.com/inventor/kazunobu-tokunaga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazunobu Tokunaga: Innovator in Adiponectin Production Enhancement

Introduction

Kazunobu Tokunaga is a notable inventor based in Fujisawa, Japan. He has made significant contributions to the field of biotechnology, particularly in the enhancement of adiponectin production. His work is crucial in addressing various health issues associated with obesity.

Latest Patents

Kazunobu Tokunaga holds a patent for an adiponectin production enhancer. This invention comprises sericin as an active ingredient and is designed to prevent and ameliorate diseases caused by reduced blood adiponectin levels. These diseases include arteriosclerosis, fatty liver, and diabetes associated with obesity. The enhancer, along with its pharmaceutical composition and food and drink applications, demonstrates excellent safety and effectiveness in enhancing adiponectin production.

Career Highlights

Kazunobu Tokunaga is affiliated with Seiren Kabushiki Kaisha, where he continues to innovate in the field of health and nutrition. His work has the potential to be broadly applied in various pharmaceutical preparations and food products, making a significant impact on public health.

Collaborations

He has collaborated with notable colleagues such as Norihisa Kato and Kazuhisa Tsujimoto, contributing to advancements in their respective fields.

Conclusion

Kazunobu Tokunaga's innovative work in adiponectin production enhancement showcases his commitment to improving health outcomes related to obesity. His contributions are expected to have a lasting impact on both pharmaceutical and food industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…